Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.

The objective of this study was to extend our previous research and to further characterize the humoral immune responses against HIV-1 p24, gp41 and the specific peptides carrying the immunodominant epitopes (IDEs) that react with human serum samples from HIV-1-infected individuals in China. We foun...

Full description

Bibliographic Details
Main Authors: Xiufen Li, Yue Wu, Xuqi Ren, Shuyun Deng, Guifang Hu, Shouyi Yu, Shixing Tang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5089721?pdf=render
_version_ 1818908980432338944
author Xiufen Li
Yue Wu
Xuqi Ren
Shuyun Deng
Guifang Hu
Shouyi Yu
Shixing Tang
author_facet Xiufen Li
Yue Wu
Xuqi Ren
Shuyun Deng
Guifang Hu
Shouyi Yu
Shixing Tang
author_sort Xiufen Li
collection DOAJ
description The objective of this study was to extend our previous research and to further characterize the humoral immune responses against HIV-1 p24, gp41 and the specific peptides carrying the immunodominant epitopes (IDEs) that react with human serum samples from HIV-1-infected individuals in China. We found that the majority (90.45%, 180/199) of the samples did not react with any of the three HIV-1 p24 peptides carrying IDEs, but did react with the recombinant full-length p24, suggesting that these samples tested in China were primarily directed against the conformational epitopes of HIV-1 p24. In contrast, 84.54% (164/194) of the samples reacted with at least one HIV-1 linear gp41 peptide, in particular the gp41-p1 peptide (amino acids 560-616). Both recently and long-term HIV-1-infected individuals displayed similar humoral immune responses against the recombinant gp41. However, samples from long-term HIV-1-infected subjects but not from recently infected subjects, showed a very strong reaction against the gp41-p1 peptide. The different response patterns observed for the two groups against the gp41 and the peptide gp41-p1 were statistically significant (P<0.01, Chi-square test). These results have direct relevance and importance for design of improved HIV-1 p24 detection assays and the gp41- based immunoassay that can be used to reliably distinguish recent and long-term HIV-1 infection.
first_indexed 2024-12-19T22:19:38Z
format Article
id doaj.art-4c298e875cc6426a87d49050c3dc898b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T22:19:38Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4c298e875cc6426a87d49050c3dc898b2022-12-21T20:03:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011111e016587410.1371/journal.pone.0165874Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.Xiufen LiYue WuXuqi RenShuyun DengGuifang HuShouyi YuShixing TangThe objective of this study was to extend our previous research and to further characterize the humoral immune responses against HIV-1 p24, gp41 and the specific peptides carrying the immunodominant epitopes (IDEs) that react with human serum samples from HIV-1-infected individuals in China. We found that the majority (90.45%, 180/199) of the samples did not react with any of the three HIV-1 p24 peptides carrying IDEs, but did react with the recombinant full-length p24, suggesting that these samples tested in China were primarily directed against the conformational epitopes of HIV-1 p24. In contrast, 84.54% (164/194) of the samples reacted with at least one HIV-1 linear gp41 peptide, in particular the gp41-p1 peptide (amino acids 560-616). Both recently and long-term HIV-1-infected individuals displayed similar humoral immune responses against the recombinant gp41. However, samples from long-term HIV-1-infected subjects but not from recently infected subjects, showed a very strong reaction against the gp41-p1 peptide. The different response patterns observed for the two groups against the gp41 and the peptide gp41-p1 were statistically significant (P<0.01, Chi-square test). These results have direct relevance and importance for design of improved HIV-1 p24 detection assays and the gp41- based immunoassay that can be used to reliably distinguish recent and long-term HIV-1 infection.http://europepmc.org/articles/PMC5089721?pdf=render
spellingShingle Xiufen Li
Yue Wu
Xuqi Ren
Shuyun Deng
Guifang Hu
Shouyi Yu
Shixing Tang
Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.
PLoS ONE
title Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.
title_full Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.
title_fullStr Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.
title_full_unstemmed Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.
title_short Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.
title_sort characterization of humoral immune responses against capsid protein p24 and transmembrane glycoprotein gp41 of human immunodeficiency virus type 1 in china
url http://europepmc.org/articles/PMC5089721?pdf=render
work_keys_str_mv AT xiufenli characterizationofhumoralimmuneresponsesagainstcapsidproteinp24andtransmembraneglycoproteingp41ofhumanimmunodeficiencyvirustype1inchina
AT yuewu characterizationofhumoralimmuneresponsesagainstcapsidproteinp24andtransmembraneglycoproteingp41ofhumanimmunodeficiencyvirustype1inchina
AT xuqiren characterizationofhumoralimmuneresponsesagainstcapsidproteinp24andtransmembraneglycoproteingp41ofhumanimmunodeficiencyvirustype1inchina
AT shuyundeng characterizationofhumoralimmuneresponsesagainstcapsidproteinp24andtransmembraneglycoproteingp41ofhumanimmunodeficiencyvirustype1inchina
AT guifanghu characterizationofhumoralimmuneresponsesagainstcapsidproteinp24andtransmembraneglycoproteingp41ofhumanimmunodeficiencyvirustype1inchina
AT shouyiyu characterizationofhumoralimmuneresponsesagainstcapsidproteinp24andtransmembraneglycoproteingp41ofhumanimmunodeficiencyvirustype1inchina
AT shixingtang characterizationofhumoralimmuneresponsesagainstcapsidproteinp24andtransmembraneglycoproteingp41ofhumanimmunodeficiencyvirustype1inchina